This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04035/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04035/identifier/pubchem-compound/
n14http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB04035/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04035/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04035/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04035
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB04035 n14:DB04035
dcterms:title
Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate
adms:identifier
n9:DB04035 n10:CB4 n11:4722090 n12:5849540 n13:46505116
n4:IUPAC-Name
n5:271B5AC2-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B5AC8-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B5AC7-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B5AC4-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B5AC5-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B5AC6-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B5AC0-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B5AC1-363D-11E5-9242-09173F13E4C5 n5:271B5ABE-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B5ABF-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B5ACE-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B5ACF-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B5AC9-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B5ACA-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B5ACC-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B5ACB-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B5ACD-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B5AD4-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B5AD6-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B5AD7-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B5AD3-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B5AD2-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B5AD5-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B5AC3-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5AD0-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B5AD1-363D-11E5-9242-09173F13E4C5